SAN DIEGO, May 30, 2012 /PRNewswire/ -- Accelrys, Inc.
(NASDAQ: ACCL), a leading enterprise R&D software and services
company, today announced that the Gulf Coast Consortia (GCC) for
Quantitative Biomedical Sciences has signed a five-year licensing
agreement with Accelrys to provide investigators in the GCC
Chemical Genomics (GCC-CG) program with access to scientific
software, services and training. The Accelrys software will be used
to support multi-disciplinary collaborative research and training
programs for the treatment and prevention of diseases, including
rare and undertreated cancers.
To view the multimedia assets associated with this release,
please click
http://www.prnewswire.com/news-releases/accelrys-announces-software-licensing-agreement-with-gulf-coast-consortia-155506635.html
Offered through the Accelrys Academic Program, the licensed
software includes the scientifically enabled, enterprise-scalable
Accelrys Enterprise Platform supporting multi-center, collaborative
information sharing and scientific innovation across partnering
research organizations. The system also includes Accelrys Pipeline
Pilot™ (the platform's scientific authoring solution), the
Cloud-based Accelrys HEOS® drug discovery information
management workspace, the Accelrys Discovery Studio® modeling and
simulation application and Accelrys Biological Registration
software.
"Plug-and-play deployment and ease of use in a seamless
integrated network requiring minimal support by internal resources
were the driving factors that led our group to adopt Accelrys
technology," said GCC-CG director and co-founder Dr. Peter Davies, professor and director of the
Center for Translational Cancer Research, Institute of Biosciences
and Technology, Texas A&M Health Center. "With upwards of
thirty projects a year, we need to work together efficiently and
generate results quickly with minimal time and resources spent on
internal software development. The ability to create Pipeline Pilot
Web applications that can be freely shared with other academic
researchers inside or outside the Consortia provides a significant
collaboration and innovation benefit."
Dr. Michael Mancini, associate
professor in the department of Molecular and Cellular Biology at
Baylor College of Medicine, and
co-founder/co-director of the GCC-CG added "For several years, our
assay development efforts and screening program have always had a
sizable high throughput microscopy-based emphasis using Pipeline
Pilot-based imaging tools. We are extremely pleased to now be able
to integrate high content analysis/screening data and reporting
across the entire program using HEOS."
The mission of the GCC is to build and support interdisciplinary
collaborative research teams and training programs in the
biological sciences and apply the resulting expertise and knowledge
to the treatment and prevention of diseases. The GCC brings
together preeminent principal investigators from several
world-renowned research institutions including the founding
members:
- Baylor College of Medicine
- Rice University
- University of Houston
- University of Texas Health Science Center
at Houston (UTHealth)
- University of Texas MD Anderson
Cancer Center
- University of Texas Medical Branch
at Galveston
In addition to the GCC founding institutions, the GCC-CG
includes The Methodist Hospital Research Institute, The
University of Texas at Austin - Texas
Institute for Drug and Diagnostic Development, Texas A&M Health Science Center – Institute for
Biosciences and Technology, Texas Southern
University and The University of
Texas-El Paso.
"Large inter-institutional cooperatives focused on collaborative
research and interdisciplinary training represent a new operating
paradigm in academia today," said Accelrys Senior Vice President
and Chief Technology Officer, Dr. Matt
Hahn. "Accelrys' unifying Enterprise Platform defines a new
standard in integrated research informatics for multi-center
collaborations. The software package tailored for GCC and delivered
through Accelrys' Academic Program provides immediate access to
shared state-of-the-art solutions, enabling university partners to
hit the ground running with project delivery."
Visit the Accelrys Academic microsite to learn more about how
the Accelrys Academic Program is advancing academic research.
About Accelrys, Inc.
Accelrys (NASDAQ: ACCL), a leading scientific enterprise R&D
software and services company, supports industries and
organizations that rely on scientific innovation to differentiate
themselves. The industry-leading Accelrys Enterprise Platform
provides a broad, flexible scientific solution optimized to
integrate the diversity of science, experimental processes and
information requirements across the research, development, process
scale-up and early manufacturing phases of product development. By
incorporating capabilities in applications for modeling and
simulation, enterprise lab management, workflow and automation, and
data management and informatics, Accelrys enables scientific
innovators to access, organize, analyze and share data in
unprecedented ways, ultimately enhancing innovation, improving
productivity and compliance, reducing costs and speeding time from
lab to market.
Accelrys solutions are used by more than 1,300 customers in the
pharmaceutical, biotechnology, energy, chemicals, aerospace,
consumer packaged goods and industrial products industries.
Headquartered in San Diego,
Calif., Accelrys employs more than 200 full-time PhD
scientists. For more information about Accelrys, visit
www.accelrys.com.
Press Inquiries
Racepoint Group
For Accelrys
Marla Kertzman, 415-694-6701
mkertzman@racepointgroup.com
SOURCE Accelrys, Inc.